| 标题 |
Clinical benefit of luspatercept in erythropoiesis-stimulating agent (ESA)-naive patients (pts) with early disease characteristics and very low-, low-, or intermediate-risk Myelodysplastic Syndromes (LR-MDS): A post hoc analysis from the commands trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Blood 作者:Valeria Santini; Matteo Della Porta; Rami Komrokji; Veronika Pozharskaya; Thalia Farazi; et al 出版日期:2025-12-05 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)